Analysts Rating: P3 Health Partners Inc (NASDAQ:PIII) Stock Won “a Neutral” Rating From BTIG Research
BTIG Research raised the price target for the P3 Health Partners Inc (NASDAQ:PIII) stock from “a Buy” to “a Neutral”. The rating was released on April 01, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the […]
Ladenburg Thalmann Assigned “a Buy” Rating to Aptevo Therapeutics Inc (NASDAQ:APVO) Stock
Ladenburg Thalmann raised the price target for the Aptevo Therapeutics Inc (NASDAQ:APVO) stock to “a Buy”. The rating was released on November 05, 2018, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]
Yield10 Bioscience Inc (NASDAQ:YTEN) stock Market Value Reached at $3.61 million: What Happened?
Lake Street raised the price target for the Yield10 Bioscience Inc (NASDAQ:YTEN) stock from “a Buy” to “a Hold”. The rating was released on February 08, 2024, according to finviz. The research report from National Securities has upgraded the stock from Neutral to Buy, with a price target set at $15. Historical Earnings Surprises and […]
Recent trade makes Pinterest Inc (PINS) Stock an appealing buy
Argus raised the price target for the Pinterest Inc (NYSE:PINS) stock from “a Hold” to “a Buy”. The rating was released on January 18, 2024, according to finviz. The research report from Raymond James has resumed the stock to Outperform, with a price target set at $45. The stock was upgraded by RBC Capital Mkts, […]
Is price-to-earnings ratio of 18.82 for Berry Corp (NASDAQ:BRY) Stock digestible?
Piper Sandler raised the price target for the Berry Corp (NASDAQ:BRY) stock from “an Overweight” to “a Neutral”. The rating was released on August 14, 2023, according to finviz. We previously noted in another research note published on July 17, 2023 by Jefferies that downgraded the stock from a Buy to a Hold with a […]
Vermilion Energy Inc (NYSE:VET) Stock is trading Lower -6.35% From 200-Day SMA
TD Securities raised the price target for the Vermilion Energy Inc (NYSE:VET) stock from “a Hold” to “a Buy”. The rating was released on March 27, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -0.50% within the last five trades and 2.83% […]
The Benchmark Company Assigned “a Hold” Rating to Cactus Inc (NYSE:WHD) Stock
The Benchmark Company raised the price target for the Cactus Inc (NYSE:WHD) stock from “a Buy” to “a Hold”. The rating was released on January 16, 2024, according to finviz. We previously noted in another research note published on October 17, 2023 by Barclays that upgraded the stock from an Equal weight to an Overweight […]
Citigroup raised the price target for the Evolent Health Inc (NYSE:EVH) stock to “”a Buy””
Citigroup raised the price target for the Evolent Health Inc (NYSE:EVH) stock to “a Buy”. The rating was released on April 22, 2024, according to finviz. The research report from Barclays has initiated the stock to Overweight, with a price target set at $39. The stock was initiated by JMP Securities, who disclosed in a […]
Embraer S.A. ADR (NYSE:ERJ) stock Posted Gross Margin of 17.23 percent in Last Year: Is Justifiable?
UBS raised the price target for the Embraer S.A. ADR (NYSE:ERJ) stock from “a Buy” to “a Neutral”. The rating was released on March 26, 2024, according to finviz. We previously noted in another research note published on February 06, 2024 by HSBC Securities that downgraded the stock from a Buy to a Hold with […]
Jabil Inc (JBL) Stock Is Looking Attractive
Argus raised the price target for the Jabil Inc (NYSE:JBL) stock from “a Buy” to “a Hold”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on January 17, 2024 by Barclays that reiterated the stock to an Overweight with a price target of $151 […]
